HALIX started Construction Activities for the new facility

Kick-off for the construction activities for a 6.700 m² brand-new GMP facility at the Leiden Bio Science Park

Leiden (the Netherlands), 02.07.2018 – With an official ground-breaking ceremony, HALIX has kicked off the construction activities for a 6.700 m² brand-new GMP facility at the Leiden Bio Science Park. This new facility will enable HALIX to further expand its business.

On behalf of Droege Group, Dr. Ernest Droege, CEO of the company, and Dr. Hedda im Brahm-Droege, Member of Supervisory Board, started the ceremonial actions.

Dr. Harry Flore, CEO of HALIX, is proud to kick-start the construction activities for the new facility: “This is a milestone that creates a solid base for a bright future of HALIX.”, says Dr. Harry Flore.

HALIX is a contract development & manufacturing organization (CDMO) and licensed for clinical and commercial GMP contract manufacturing of biopharmaceuticals. We provide services to biopharmaceutical partners, enabling them to harvest on their research activities, and to enter and supply their markets with the most efficient use of resources. Our focus is GMP manufacturing of biologics, by manufacturing drug substance on eucaryotic cells, and by performing aseptic fill and finish and lyophilization services. Within the next years, we are extending our scope of services for therapeutic proteins and viral vaccines.

Mr. Paul Dirkse, Alderman of the Municipality of Leiden, praised HALIX for settling in the Leiden Bio Science Park and therefore contributing to the continuous development of the area.

The Leiden Bio Science Park is the largest science cluster in the Netherlands and brings together Leiden University, Leiden University Medical Center (LUMC), and approximately 150 companies in close proximity. There is a lot of energy and expertise moving around between companies in the Bio Science Park. Being part of that is a great benefit for HALIX.

About HALIX

HALIX B.V. is a biopharmaceutical contract development and manufacturing organization (CDMO) for biologics enabling the treatment and prevention of life threatening diseases. The company is focused on mammalian expression systems for the production of viral vectors and recombinant proteins. HALIX leverages scalable single-use, state-of-the-art bioprocessing technologies to provide its customers with services for the development and GMP manufacturing of drug substance and drug product. HALIX has entered into a number of contracts for the production of oncolytic immunotherapies and vaccines, utilizing innovative technologies. The company opened its state-of-the-art 6,700 m2 GMP manufacturing facility in 2019, offering 1,000L SUB capacities, at the Leiden Bio Science Park, the Netherlands. HALIX belongs to the family owned Droege Group AG. More information is available on: www.halix.nl.

About Droege Group

Droege Group (founded in 1988) is an independent advisory and investment company under full family ownership. The company acts as a specialist for tailor-made transformation programs aiming to enhance corporate value. Droege Group combines its corporate family-run structure and capital strength into a family-equity business model. The group carries out direct investments with its own equity in corporate spin-offs and medium-sized companies in “special situations”. With the guiding principle “execution – following the rules of art”, the group is a pioneer in execution-oriented corporate development. Droege Group follows a focused investment strategy based on current megatrends (knowledge, connectivity, prevention, demography, specialization, future work, shopping 4.0). Enthusiasm for quality, innovation and speed determines the company’s actions. In recent years Droege Group has successfully positioned itself in domestic and international markets and operates in 30 countries. More information is available on www.droege-group.com.

Contact

Corporate Communications HALIX B.V.
Tel. + 31 (0)88 1959000
Email: corporate@halix.nl

Privacy settings

Accepting cookies makes our website easier to navigate, lets you find what you are looking for faster and helps us show you information that is more likely to be of interest to you. Do you accept and consent to cookies? Please choose one of our cookie options:
 
 

  • Remember which cookies group you accepted

  • Remember your login details
  • Essential: Remember your cookie permission setting
  • Essential: Allow session cookies
  • Essential: Gather information you input into a contact forms newsletter and other forms across all pages
  • Essential: Keep track of what you input in a shopping cart
  • Essential: Authenticate that you are logged into your user account
  • Essential: Remember language version you selected
  • Functionality: Remember social media settings
  • Functionality: Remember selected region and country
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions
  • Advertising: Tailor information and advertising to your interests based on e.g. the content you have visited before. (Currently we do not use targeting or targeting cookies.
  • Advertising: Gather personally identifiable information such as name and location

  • Essential: Remember your cookie permission setting
  • Essential: Allow session cookies
  • Essential: Gather information you input into a contact forms newsletter and other forms across all pages
  • Essential: Keep track of what you input in a shopping cart
  • Essential: Authenticate that you are logged into your user account
  • Essential: Remember language version you selected

  • Remember your login details
  • Functionality: Remember social media settings
  • Functionality: Remember selected region and country
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions
  • Advertising: Tailor information and advertising to your interests based on e.g. the content you have visited before. (Currently we do not use targeting or targeting cookies)
  • Advertising: Gather personally identifiable information such as name and location

  • Functional: to accept functional cookies which are necessary to let the HALIX website (halix.nl) function.
  • Analytics: to accept functional cookies which are necessary to let the HALIX website (halix.nl) function and analytical cookies which we use to measure and analyse visits to our website.

  • Functional: to accept functional cookies which are necessary to let the HALIX website (halix.nl) function.
  • Analytics: to accept functional cookies which are necessary to let the HALIX website (halix.nl) function and analytical cookies which we use to measure and analyse visits to our website.

  • Functionality: Remember social media settings
  • Functionality: Remember selected region and country
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions
  • Advertising: Tailor information and advertising to your interests based on e.g. the content you have visited before. (Currently we do not use targeting or targeting cookies)
  • Advertising: Gather personally identifiable information such as name and location

  • Remember your login details
Save & Close